RELVAR ELLIPTA
92MCG/22MCG INH PLV DOS 1X30DÁV
| SÚKL code | 0194564 |
|---|---|
| Name of the product | RELVAR ELLIPTA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | RELVAR ELLIPTA |
| Supplement | 92MCG/22MCG INH PLV DOS 1X30DÁV |
| Strenght | 92MCG/22MCG |
| Pharmaceutical form | Inhalation powder, pre-dispensed |
| Package | 1X30DÁV |
| Route | Inhalation use |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance |
FLUTICASONE FUROATE (FLUTICASONI FUROAS) VILANTEROL TRIFENATATE (VILANTEROLI TRIFENATAS) |
| ATC group | R03AK10 |
| ATC group name | VILANTEROL A FLUTIKASON-FUROÁT |
| Doping | Beta2-agonisté (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
| Registration Number | EU/1/13/886/002 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | GlaxoSmithKline (Ireland) Limited, Dublin |
| MA Holder country | IRSKO |
cz